These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 17096649)

  • 21. Targeting the tick-pathogen interface for novel control strategies.
    de la Fuente J; Kocan KM; Almazan C; Blouin EF
    Front Biosci; 2008 May; 13():6947-56. PubMed ID: 18508707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ANTIDotE: anti-tick vaccines to prevent tick-borne diseases in Europe.
    Sprong H; Trentelman J; Seemann I; Grubhoffer L; Rego RO; Hajdušek O; Kopáček P; Šíma R; Nijhof AM; Anguita J; Winter P; Rotter B; Havlíková S; Klempa B; Schetters TP; Hovius JW
    Parasit Vectors; 2014 Feb; 7():77. PubMed ID: 24559082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A cross-reactive tick cement antigen is a candidate broad-spectrum tick vaccine.
    Trimnell AR; Davies GM; Lissina O; Hails RS; Nuttall PA
    Vaccine; 2005 Jul; 23(34):4329-41. PubMed ID: 15913855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two serine protease inhibitors (serpins) that induce a bovine protective immune response against Rhipicephalus appendiculatus ticks.
    Imamura S; Namangala B; Tajima T; Tembo ME; Yasuda J; Ohashi K; Onuma M
    Vaccine; 2006 Mar; 24(13):2230-7. PubMed ID: 16314008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccinomics, the new road to tick vaccines.
    de la Fuente J; Merino O
    Vaccine; 2013 Dec; 31(50):5923-9. PubMed ID: 24396872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling tick vaccines: a key tool to improve protection efficacy.
    de la Fuente J; Estrada-Peña A; Contreras M
    Expert Rev Vaccines; 2020 Mar; 19(3):217-225. PubMed ID: 32192377
    [No Abstract]   [Full Text] [Related]  

  • 27. Characterization of three Ixodes scapularis cDNAs protective against tick infestations.
    Almazán C; Blas-Machado U; Kocan KM; Yoshioka JH; Blouin EF; Mangold AJ; de la Fuente J
    Vaccine; 2005 Aug; 23(35):4403-16. PubMed ID: 16005748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of anti-tick cocktail vaccine against Rhipicephalus appendiculatus.
    Imamura S; Konnai S; Vaz Ida S; Yamada S; Nakajima C; Ito Y; Tajima T; Yasuda J; Simuunza M; Onuma M; Ohashi K
    Jpn J Vet Res; 2008 Aug; 56(2):85-98. PubMed ID: 18828446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of a concealed antigen Hq05 from the hard tick Haemaphysalis qinghaiensis and its effect as a vaccine against tick infestation in sheep.
    Gao J; Luo J; Fan R; Schulte-Spechtel UC; Fingerle V; Guan G; Zhao H; Li Y; Ren Q; Ma M; Liu Z; Liu A; Dang Z; Sugimoto C; Yin H
    Vaccine; 2009 Jan; 27(3):483-90. PubMed ID: 19010370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The current status of major tick borne diseases in Zambia.
    Makala LH; Mangani P; Fujisaki K; Nagasawa H
    Vet Res; 2003; 34(1):27-45. PubMed ID: 12588682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cloning, expression and immunoprotective efficacy of rHaa86, the homologue of the Bm86 tick vaccine antigen, from Hyalomma anatolicum anatolicum.
    Azhahianambi P; De La Fuente J; Suryanarayana VV; Ghosh S
    Parasite Immunol; 2009 Mar; 31(3):111-22. PubMed ID: 19222782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using genomic approaches to unravel livestock (host)-tick-pathogen interactions.
    Jensen K; de Miranda Santos IK; Glass EJ
    Trends Parasitol; 2007 Sep; 23(9):439-44. PubMed ID: 17656152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Translational biotechnology for the control of ticks and tick-borne diseases.
    de la Fuente J
    Ticks Tick Borne Dis; 2021 Sep; 12(5):101738. PubMed ID: 34023540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subolesin/Akirin vaccines for the control of arthropod vectors and vectorborne pathogens.
    de la Fuente J; Moreno-Cid JA; Galindo RC; Almazan C; Kocan KM; Merino O; Perez de la Lastra JM; Estrada-Peña A; Blouin EF
    Transbound Emerg Dis; 2013 Nov; 60 Suppl 2():172-8. PubMed ID: 24589118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current status and future prospects of multi-antigen tick vaccine.
    Parthasarathi BC; Kumar B; Ghosh S
    J Vector Borne Dis; 2021; 58(3):183-192. PubMed ID: 35170454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Innovative approaches for the control of ticks and tick-borne diseases.
    de la Fuente J; Mazuecos L; Contreras M
    Ticks Tick Borne Dis; 2023 Nov; 14(6):102227. PubMed ID: 37419001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of reverse vaccinology approaches for the development of vaccines against ticks and tick borne diseases.
    Lew-Tabor AE; Rodriguez Valle M
    Ticks Tick Borne Dis; 2016 Jun; 7(4):573-85. PubMed ID: 26723274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mapping protective epitopes in the tick and mosquito subolesin ortholog proteins.
    Prudencio CR; Pérez de la Lastra JM; Canales M; Villar M; de la Fuente J
    Vaccine; 2010 Jul; 28(33):5398-406. PubMed ID: 20594626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Passive immunization with monoclonal antibodies: effects on Haemaphysalis longicornis tick infestation of BALB/c mice.
    Nakajima M; Yanase H; Iwanaga T; Kodama M; Ohashi K; Onuma M
    Jpn J Vet Res; 2003 Feb; 50(4):157-63. PubMed ID: 12675551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tick modulation of host cytokines.
    Wikel SK
    Exp Parasitol; 1996 Nov; 84(2):304-9. PubMed ID: 8932782
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.